Comanche Biopharma is a preclinical biopharmaceutical company developing a novel siRNA therapy for the treatment of preeclampsia. The Company’s purpose is to lower the risks of pregnancy and prematurity worldwide by safely sustaining natural pregnancy and allowing for fetal maturation. Comanche envisions a world where all pregnant women have access to safe and effective therapies that are evidence-based, cost-effective and sustainable.
Go to website: https://comanchebiopharma.com